Uber-Backed Lime Plans Debt as IPO Push Faces Market Test
Lime, the e-scooter and e-bike maker backed by Uber, aims for a 2026 IPO, even as mounting debt and a tighter funding...
Wealth Building Tips From Financial Experts
Learn wealth building tips from financial experts that can help you enhance your financial strategy and secure your future.
19,767 articles
Aveanna Healthcare Stock 23% Jump: Why a Fund Sold $16M
Aveanna Healthcare stock jumped 23%, but a major fund still sold $16 million of AVAH shares. This article breaks down...
Foxman, Longtime Anti-Defamation Leader, Dies at 86
Abe Foxman, the longtime director of the Anti-Defamation League, has died at age 86. His 28-year tenure shaped anti-h...
Netflix vs Disney: Only Winner Emerges in Streaming War
Netflix reports revenue growth driven by ads and a leaner strategy, while Disney posts margins and park revenue gains...
Astronics (ATRO) 2026 Earnings Outlook for Investors
Astronics reports a mixed Q1 2026 that tests the durability of its backlog and margin recovery. This article breaks d...
Bitcoin ETFs Shed $630m: What It Means for Crypto Investors
A watershed moment hit crypto markets as bitcoin etfs shed $630m in one day. This article breaks down what drove the ...
Forget Trump Beijing Trade: Stock with 27 Quarters of Growth
A Latin American e-commerce and fintech stock posts 27 consecutive quarters of 30%+ revenue growth, defying geopoliti...
America Could Soon Oversupplied with Homes: What It Means for Loans
A shifting housing supply could change how loans are priced and approved. This article breaks down what oversupply me...
Moviegoers Still Hungry Sanitized Biopic Tops Box Office
The Michael biopic reclaimed the top spot with a domestic 26.1M, while Prada 2 trailed in second. New releases also j...
Growth Stocks Down That Could Be Long-Term Winners
When great growth ideas stumble, the long-term case often remains intact. This piece examines two names that have fal...
Why Relay Therapeutics Stock Popped This Wednesday
A dramatic one-day move put Relay Therapeutics in the spotlight. After encouraging Phase 2 results for zovegalisib an...
Opinion: AbbVie Best Dividend Stock for an Uncertain Market
In today’s uncertain markets, income-focused investors are weighing reliable cash flow over flashy growth. This piece...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status